AYALA PHARMACEUTICALS INC has a total of 32 patent applications. Its first patent ever was published in 2019. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are LABORATORIOS LETI S L UNIPERSONAL, REMEGEN LTD and ASCENDIS PHARMA ONCOLOGY DIV A/S.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 4 | |
#3 | Brazil | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Canada | 3 | |
#6 | Republic of Korea | 3 | |
#7 | Singapore | 3 | |
#8 | United States | 3 | |
#9 | China | 2 | |
#10 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Sidransky David | 16 |
#2 | Davis Matti | 9 |
#3 | David Sidransky | 3 |
#4 | Mamluk Roni | 2 |
#5 | Bruce S Fischer | 1 |
#6 | Matti Davis | 1 |
#7 | Peled Amnon | 1 |
#8 | Fischer Bruce S | 1 |
#9 | Bajaj Gaurav | 1 |
#10 | Gaurav Bajaj | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020232191A1 | Bisfluoroalkyl-1,4-benzodiazepin one compounds for treating notch-activated breast cancer | |
EP3793564A1 | Compositions comprising bisfluoroalkyl-l,4-benzodiazepinone compounds for treating adenoid cystic carcinoma | |
CA3101340A1 | Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and immunotherapeutics and methods of use thereof | |
WO2019215585A1 | Compositions comprising cd20 inhibitors and bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof | |
SG11202011041YA | Combination compositions comprising bisfluoroalkyl-1,4- benzodiazepinone compounds and methods of use thereof |